Verastem, Inc. (VSTM)
9.27
-0.34
(-3.54%)
USD |
NASDAQ |
Dec 15, 16:00
9.07
-0.20
(-2.16%)
After-Hours: 06:39
Verastem Research and Development Expense (Annual): 81.33M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CorMedix, Inc. | 3.942M |
| Anavex Life Sciences Corp. | 37.59M |
| Ocugen, Inc. | 30.16M |
| Syndax Pharmaceuticals, Inc. | 241.64M |
| AnaptysBio, Inc. | 163.23M |